LCH encompasses a group of disorders of unknown origin with widely diverse clinical presentations and outcomes, characterized by infiltration of the involved tissues by large numbers of LC. LCH is characterized clinically by various combinations of systemic and cutaneous manifestations. LCH consists of Letterer-Siwe disease, Hand-Schuller-Christian disease, eosinophilic granuloma, and congenital self-healing reticulohistiocytosis
1.
The definite diagnosis of LCH should fit light microscopy histology and at least 1 of the 2 following factors: 1) Birbeck's granules by electron microscopy, 2) labeling of CD1 antigen on pathological cells
2. On light microscopy, the typical LCH cells are approximately four to five times larger than lymphocytes and have a vesiculated, reniform (kidney-shaped) nucleus and abundant, slightly eosinophilic cytoplasm. Sometimes, indeterminate cell histiocytosis (ICH) closely resembles LCH clinically and histologically. The cells in ICH are positive for S-100 protein, but show variable reactivity for CD1a. Macrophage markers, such as KP1 (CD68) and Ki-M1p, are often positive. No Birbeck granules are seen ultrastructurally
3. In this case, we confirmed LCH by his past history, many LC infiltration in H&E stain and immunochemical positivity for S-100 protein and CD1a and negativity for macrophage markers.
Five cases of adult cutaneous LCH were noted in Korean Dermatologic literature ()
4-8. Although LCH is commonly thought to be confined to children, a small percentage of patients are elderly and may have cutaneous involvement for many years before the onset of visceral disease
9. Adult LCH has difference with childhood LCH in organ involvement. Bone disease is most common in childhood LCH, but pulmonary disease is very frequent in adult LCH. Skin disease and diabetes insipidus are frequent in both type
10.
| Table 1Cases of adult LCH in Korean literature |
Cutaneous manifestations are common in multi-organ involved LCH and adult LCH skin lesions are similar that of childhood. The typical lesion is yellowish or reddish small multiple papules with ulceration, crusting or a hemorrhagic change on the trunk and scalp. Especially the scalp lesions resemble seborrheic dermatitis and other common finding is an eczematous lesion on intertriginous area
11.
On the other hand, unusual cutaneous manifestations of LCH such as varicelliform eruption, solitary nodule and nail fold swelling are also reported ()
12-19. In this case, cutaneous lesions are shown as brown lichenoid patches on left dorsal foot and we consider this is rare in LCH patients.
| Table 2Unusual cutaneous manifestations of LCH |
Surgery, steroid cream, topical nitrogen mustard, interferon IL, PUVA, isotretinoin, thalidomide can be treatment for skin manifestations of LCH. Single system-patients should receive prednisone and vinblastine for 6 wk followed by continuation treatment with 6-mercaptopurine, prednisone, and vinblastine for 6 months. Patients with multisystem disease should receive prednisone and vinblastine for 6 wk followed by continuation treatment with 6-mercaptopurine, prednisone, and vinblastine for 6 or 12 months, respectively
20.
LCH presents a very wide clinical spectrum and variable course. Prognostic factors are including age of patients at diagnosis, numbers of organ involved and organ dysfunction. Single system disease is usually associated with a good prognosis, but multisystem disease may be fatal
11.